Sudip Das

Sudip Das

Auto-generated profile, based on publicly available information

Sudip Das

Department of Biotechnology, Haldia Institute of Technology, Haldia, ICARE Complex, HIT Campus, Purba Medinipur-721657, West Bengal, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
DRDjamila M. Rojoa
Djamila M. Rojoa
FRFiras J Raheman
Firas J Raheman
YSYougan Saman
Yougan Saman
BMBassem Mettias
Bassem Mettias
SDSudip Das
Sudip Das
PRP A Rea
P A Rea
Background: The increased incidence of necrotising otitis externa over the last decade has had a significant burden on healthcare providers. Several factors may affect outcome, and stratifying risk may allow personalised treatment. Method: Retrospectively identified patients were prospectively surveyed over 12 months. The Cox proportional hazards model was used to identify predictors of poor prognosis. Results: Twenty-six patients with necrotising otitis externa (average age of 80 years) were admitted from 2018 to 2019. At one year, 19 per cent mortality was observed. A high Charlson Comorbidity Index was associated with increased mortality ( p = 0.03), prolonged in-patient stay ( p = 0.047) and increased odds of adverse outcomes (odds ratio = 1.48, 95 per cent confidence interval = 0.26–2.67, p = 0.019). The Charlson Comorbidity Index in our prognostic model was validated using the receiver operating characteristic curve (area under the curve = 0.76). Charlson Comorbidity Index score of 5 or more independently predicted one-year morbidity and mortality (hazard ratio = 1.30, 95 per cent confidence interval = 0.94–1.79, p = 0.03). Conclusion: Risk-stratifying patients may enable clinicians to holistically counsel patients and tailor their treatment to improve their prognosis and subsequently alleviate the burden of necrotising otitis externa.

24 August 2023 in arXiv
Verified
Preprint
Open access
PDF file
SDSubhrajyoti Dasgupta
Subhrajyoti Dasgupta
ADArindam Das
Arindam Das
Senthil YogamaniSenthil Yogamani
Senthil Yogamani
SDSudip Das
Sudip Das
CECiaran Eising
Ciaran Eising
UBUjjwal Bhattacharya
Ujjwal Bhattacharya
Shadows are frequently encountered natural phenomena that significantly hinder the performance of computer vision perception systems in practical settings, e.g., autonomous driving. A solution to this would be to eliminate shadow regions from the images before the processing of the perception system. Yet, training such a solution requires pairs of aligned shadowed and non-shadowed images which are difficult to obtain. We introduce a novel weakly supervised shadow removal framework UnShadowNet trained using contrastive learning. It is composed of a DeShadower network responsible for the removal of the extracted shadow under the guidance of an Illumination network which is trained adversarially by the illumination critic and a Refinement network to further remove artefacts. We show that UnShadowNet can be easily extended to a fully-supervised set-up to exploit the ground-truth when available. UnShadowNet outperforms existing state-of-the-art approaches on three publicly available shadow datasets (ISTD, adjusted ISTD, SRD) in both the weakly and fully supervised setups.

1 January 2025
Verified
Book Chapter
Open access
PDF file
SDSudip Das
Sudip Das
Matrix metalloproteinases (MMPs) are family of zinc containing calcium dependent enzymes that have the capacity to degrade almost every component of the ECM in normal as well as in abnormal conditions. MMPs have been found in vertebrates, invertebrates and also plants. The functions of MMPs are intricately regulated by its specific endogenous regulators or the inhibitors known as tissue inhibitor of metalloproteinases (TIMPs) at the time of activation and inhibition of the enzymes. MMPs and TIMPs are involved in the regulation of cell characteristics in normal as well as the state of human morbidity and mortality. There are numerous roles of MMPs and/or TIMPs in normal physiological processes like tissue remodelling and development, wound healing, angiogenesis, immune response and inflammation, cell proliferation and cell signalling that are good. Again, the ugly is the abnormal activity or over expression of MMPs and/or TIMPs that have the distinct role in many disease processes like diabetes, arthritis, fibrosis, cardiovascular diseases and cancer. When the expression of MMPs is altered, it can generate the abnormal degradation of the ECM, thus highlighting MMPs as promising therapeutic targets. Within the ECM, TIMPs inhibit the proteolytic activity of MMPs. TIMPs are important regulators of ECM turnover, inflammation, cell proliferation, tissue remodeling, wound healing and cellular behaviour thereby releasing growth factors beneficial for cellular repair and differentiation. An interruption in the balance between MMPs and TIMPs has been implicated in the progression of several diseases. Such as, the development of chronic degenerative diseases, vascular complication, neurodegeneration, cancer progression and several other diseases. This chapter focuses on the participation of both MMPs and TIMPs in physiological as well as pathological processes and on how their abnormal regulation is associated with several diseases. The inclusion of current strategies and mechanisms of MMP inhibition in the development of new therapies targeting MMPs was also considered.